Ilsung Pharm (003120) — Net Asset Quality Index
Ilsung Pharm (003120) has a Net Asset Quality Index of 94.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩402.93 Billion minus total liabilities of ₩24.00 Billion yields net assets of ₩378.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Ilsung Pharm (003120) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilsung Pharm Net Asset Quality Index Over Time (2013–2025)
This chart shows how Ilsung Pharm's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 94.0%, representing net assets of ₩378.93 Billion against total assets of ₩402.93 Billion KRW. For live market cap and overall valuation, see Ilsung Pharm (003120) market capitalisation.
Annual Net Asset Quality Index for Ilsung Pharm (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Ilsung Pharm from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Ilsung Pharm strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.9% | ₩386.34 Billion | ₩403.01 Billion | ₩16.67 Billion | ▼ -1.2 pp |
| 2024 | 97.0% | ₩385.13 Billion | ₩396.88 Billion | ₩11.75 Billion | ▲ +5.7 pp |
| 2023 | 91.3% | ₩382.75 Billion | ₩419.19 Billion | ₩36.44 Billion | ▲ +1.2 pp |
| 2022 | 90.1% | ₩445.57 Billion | ₩494.42 Billion | ₩48.85 Billion | ▼ -3.0 pp |
| 2021 | 93.1% | ₩345.91 Billion | ₩371.38 Billion | ₩25.47 Billion | ▼ -0.5 pp |
| 2020 | 93.6% | ₩347.48 Billion | ₩371.22 Billion | ₩23.75 Billion | ▲ +0.1 pp |
| 2019 | 93.5% | ₩345.49 Billion | ₩369.52 Billion | ₩24.03 Billion | ▲ +0.1 pp |
| 2018 | 93.4% | ₩324.34 Billion | ₩347.26 Billion | ₩22.93 Billion | ▲ +0.5 pp |
| 2017 | 92.9% | ₩322.83 Billion | ₩347.46 Billion | ₩24.64 Billion | ▼ -1.7 pp |
| 2016 | 94.6% | ₩320.10 Billion | ₩338.50 Billion | ₩18.40 Billion | ▲ +7.8 pp |
| 2015 | 86.7% | ₩318.34 Billion | ₩367.03 Billion | ₩48.69 Billion | ▼ -0.1 pp |
| 2014 | 86.9% | ₩328.68 Billion | ₩378.37 Billion | ₩49.69 Billion | ▲ +0.3 pp |
| 2013 | 86.6% | ₩322.74 Billion | ₩372.66 Billion | ₩49.92 Billion | — |